Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway

Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway

Xinhui Wu,1,2,* Kangxian Zhao,1,2,* Xiaoxin Fang,3,4 Feng Lu,3,4 Weikang Zhang,1,2 Xiaoting Song,1,2 Lihua Chen,5 Jiacheng Sun,1,2 Haixiao Chen1,2,4 1Wenzhou Medical University, Wenzhou, People’s Republic of China; 2Department of Orthopedics, Taizhou Hospital of Zhejiang Province Aff...

Full description

Bibliographic Details
Main Authors: Wu X, Zhao K, Fang X, Lu F, Zhang W, Song X, Chen L, Sun J, Chen H
Format: Article
Language:English
Published: Dove Medical Press 2021-11-01
Series:Drug Design, Development and Therapy
Subjects:
saikosaponin d
osteoclastogenesis
nf-κb
mapks
pi3k-akt
therapy
Online Access:https://www.dovepress.com/inhibition-of-lipopolysaccharide-induced-inflammatory-bone-loss-by-sai-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/inhibition-of-lipopolysaccharide-induced-inflammatory-bone-loss-by-sai-peer-reviewed-fulltext-article-DDDT

Similar Items